GSK1550188
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1550188, covering 2017-06-12 to 2017-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]